Get insights from Healthpoint’s Dr. Rami Harb and discover how to diagnose and assess risk for ARVC. Join us for this fourth session in our dedicated Vascular Medicine & Surgery #FocusOn Series on Friday, 12th July from 3–4 PM. Don’t miss out on this informative seminar! Register today: https://bit.ly/3RT9VrN
About us
M42 is an Abu Dhabi-based, global tech-enabled healthcare company operating at the forefront of medical advancement. The company is seeking to transform lives through innovative clinical solutions that can solve the world’s most critical health and diagnostic challenges. By harnessing unique medical and data-centric technologies, including genomics and AI, M42 is transforming the traditional healthcare ecosystem and delivering the highest level of precise, patient-centric, and preventative care. M42 has over 20,000 employees and more than 450 facilities in 26 countries around the world. M42 owns a wide portfolio of assets that includes Amana Healthcare, Biogenix Labs, Danat Al Emarat, Diaverum, HealthPoint Hospital, the HealthPlus network of specialty centers, Moorfields Eye Hospital Abu Dhabi, Imperial College London Diabetes Centre, Insights Research Organization & Solutions (IROS), Omics Center of Excellence and National Reference Laboratory, among others.
- Website
-
https://m42.ae/
External link for M42 Health
- Industry
- Hospitals and Health Care
- Company size
- 10,001+ employees
- Type
- Privately Held
Employees at M42 Health
-
Paul Jones
Accelerating the adoption of personalised medicine.
-
James Mault, MD, FACS
-
Francesco Redivo
Global Executive I Healthtech I Omics I AI I Precision Medicine I 10X Thinker I Inspiring Leader I Future Focused I Humanitarian
-
Rohaan Pereira
M42 Healthcare, IT Business Partner - M42 Healthcare, CEO's Office
Updates
-
As part of #M42’s unwavering commitment towards safeguarding public health and studying environmental problems, we’re bringing our expertise in AI and technology, in partnership with Abu Dhabi Quality and Conformity Council, to launch the first-ever Honey Quality Laboratory. This innovative partnership works to ensure the UAE’s honey is free from adulterants and contaminants, setting new standards for the industry. By leveraging our state-of-the-art tech solutions and scalable capabilities, we are ensuring high-quality produce while indirectly fostering biodiversity through vital data and real-time insights. Read the full press release on the M42 website here: https://bit.ly/45NetWF
-
Join us for the third session of our Transplant #FocusOn series as we explore how to overcome the challenges of a heart transplant. Get expert insights from Dr. Mitesh V. Badiwala as he explores common complications following transplants and the best current management techniques to combat rejection and graft dysfunction. Register for the session on Thursday, 11th July from 3–4 PM: https://bit.ly/3XUhySN
-
The Abu Dhabi Biobank, a landmark initiative by #M42 and the Department of Health Abu Dhabi, aims to transform the region’s clinical landscape by creating a foundational, diverse bio-asset to support next-generation stem cell therapies. With their ability to renew, regenerate, and preserve human tissue, stem cells act as a “bio repair kit”. By cryopreserving and storing these cells as part of cord blood banking, they can be accessed at a later time and possess remarkable potential for the treatment of complex diseases. By offering both private and public banking options, the cord blood bank, as part of Abu Dhabi Biobank is a groundbreaking initiative and strategic priority that aims to shorten waiting times for treatment, increase therapeutic access for patients, improve survival rates and reduce the economic burden on governments. Learn more, by calling 800 213 or emailing cordblood@m42.ae
-
Join the Healthpoint experts for the first session in our Physiotherapy #M42FocusOn series! Featuring insights from Dr. Huda Sultan AlBlooki, Dr. Naajil Mohasin, and Dr. Aishah Kamara, explore the impact of posture, movement, and load on spine mechanics and how to improve spine health. Register now for the session on Friday, 5th July from 3–4 PM: https://bit.ly/3VYmJQk
-
Join Dr. Monika Chawla and Dr. Ibtihag Ngeeb as they explore the relationship between obesity and fertility in the third session of our dedicated #M42FocusOn series! Discover how obesity impacts reproductive treatments, general health issues relating to obesity, and the use of weight loss drugs. Register now for the session on Tuesday, 2nd July from 3–4 PM: https://bit.ly/3L1uA9n
-
Join Dr. Andrew Ives, Consultant Pediatric Pulmonologist, from Danat Al Emarat Hospital for Women & Children Hospital for the fourth session of our Sleep Medicine #FocusOn series. Take a deep dive into obstructive sleep apnea in children, identify the symptoms, and learn about key treatment modalities for the condition. Register now for the session on Friday, 28th June from 3–4 PM: https://bit.ly/3xuKrdw
-
Discover insights surrounding the role of interventional radiology in musculoskeletal disorders during the seventh session of our dedicated #FocusOn series! Join Dr. Muhammad Imran, Dr. Umme Sara Zishan, Dr. Ahmed Hamza, and Dr. Davoud Khodatars as they outline the latest techniques in image-guided interventions and their benefits. Register now for the session on Wednesday, 26th June from 3–4 PM: https://bit.ly/3VCELWX
-
Join esteemed industry pioneer Ashish Ipe Koshy, Group Chief Operating Officer of #M42, and discover how AI is reshaping the future of personalized health. From advanced diagnostics to streamlined patient services, witness how M42 is deploying next-generation technology that encompasses every aspect of clinical care. Watch the full panel discussion on our YouTube channel - https://bit.ly/4beHP17